Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
15.89B
Market cap15.89B
Price-Earnings ratio
17.23
Price-Earnings ratio17.23
Dividend yield
—
Dividend yield—
Average volume
740.52K
Average volume740.52K
High today
$242.55
High today$242.55
Low today
$236.87
Low today$236.87
Open price
$239.38
Open price$239.38
Volume
199.32K
Volume199.32K
52 Week high
$282.15
52 Week high$282.15
52 Week low
$188.07
52 Week low$188.07

Stock Snapshot

With a market cap of 15.89B, Ascendis Pharma A/S(ASND) trades at $242.01. The stock has a price-to-earnings ratio of 17.23.

As of 2026-10-22, Ascendis Pharma A/S(ASND) stock has fluctuated between $236.87 and $242.55. The current price stands at $242.01, placing the stock +2.2% above today's low and -0.2% off the high.

The Ascendis Pharma A/S(ASND)'s current trading volume is 199.32K, compared to an average daily volume of 740.52K.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $188.07 at its lowest and $282.15 at its peak.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $188.07 at its lowest and $282.15 at its peak.

ASND News

Simply Wall St 4d
Ascendis Pharma Gets EU Panel Backing, Is The Stock Still Cheap? - Simply Wall Street

...

Ascendis Pharma Gets EU Panel Backing, Is The Stock Still Cheap? - Simply Wall Street
TipRanks 6d
Ascendis gets CHMP opinion recommending marketing authorization for TransCon CNP

Ascendis Pharma (ASND) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has adopted an opin...

Analyst ratings

100%

of 22 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.